Cardiac amyloidosis has traditionally been associated with a poor prognosis, with a median survival of less than 1 year once patients present with heart failure. As consensus guidelines recommend against implantable cardioverter-defibrillator (ICD) placement for the primary prevention of sudden cardiac ...
11.1.6 Patients with Heart Failure & Left Ventricular Dysfunction: Life Expectancy Increased by coronary artery bypass graft (CABG) surgery: Medical Therapy alone and had Poor Outcomes Curator: Aviva Lev-Ari, PhD, RN https://pharmaceuticalintelligence.com/2016/04/04/patients-with-heart-failure-left...
However, if the clinical context is not taken into consideration, the risk of misdiagnosis may be high (e.g., sarcomeric HCM, cardiac amyloidosis or even Anderson-Fabry disease). mtDNA-related diseases are potentially lethal, and death most commonly occurs due to recurrent stroke-like episodes,...
Proteins causing amyloidosis are varied; each may affect different organs and cause diverse clinical manifestations. The involvement of myocardial tissue causes cardiac amyloidosis (CA) and is associated with a poor prognosis [1]. Furthermore, CA is mainly comprised of two types: light-chain cardiac...
ratio 3.21; 95% confidence interval 1.04–9.97;p = 0.03). LV GLS could detect subtle but clinically significant cardiac dysfunction in lymphoma patients in the early stage of anticancer therapy. CTRCD may be associated with not only a reduced exercise capacity but also a worse prognosis. ...
Conclusion: Amyloidosis is relatively fatal disease. Patients often have a short life expectancy after symptom onset. Early diagnosis is crucial to proper management and better prognosis.Binay Kumar AdhikariYonggang WangBo LiQuan LiuWeihua Zhang心血管病(英文)...
Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.Cardiac involvement is the main determinant of prognosis in systemic monoclonal immunoglobulin light chain (AL) . Ventricular arrhythmias and sudden cardiac are not uncommon. The electrical events that precede sudden , and ...
To date, increased T1 times have been shown to be predictive of mortality in amyloidosis36; the utility of T1 times to predict mortality in other populations remains to be proved. Methods Participants Sixty-one participants were included in the study. All participants were older than 18 years ...
Experience of THA in patients with amyloidosis used as bridge to heart transplantation appears anecdotical [83], so far, while we face increased need for treatments among patients with cardiac amyloidosis who may receive specific treatments limited to cardiac dysfunction as bridge to heart ...
Conclusions: Our objective is to highlight the early recognition and specific medicamental treatment of cardiac amyloidosis for better patient prognosis and outcomes. Keywords: cardiac amyloidosis; transthyretin; carpal tunnel syndrome; case report; rare diseases...